CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Pharma Firms Will Need Academic Expertise Like Never Before in the Post-COVID World

In recent weeks, much has been made of the challenges arriving at a global consensus around the response to the coronavirus pandemic. However, one area for encouragement is the way in which the academic research community has aligned around the issue. Academic institutions are examining coronavirus epidemiology and pathobiology from all angles in the hope of accelerating our recovery from the crisis. Graham Mills at techspert.io shows why funding is being made available from both public and private sources to support innovation projects – estimated to be at least $985 million since the crisis began.

 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026